Last Updated on June 22, 2023

Chinese Journal of Cancer Biotherapy- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: Editorial office of Chinese Journal of Cancer Biotherapy

Abbreviation: Chin. J. Cancer Biother.




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

0.06

SJR

 0.106

h-Index

 5

Rank

 25753

Important Details

Title Chinese Journal of Cancer Biotherapy
Standard Abbreviation Chin. J. Cancer Biother.
Type of Publication Journal
Discipline Cancer Research (Q4); Molecular Medicine (Q4); Pharmacology (Q4)
Impact Score 0.06
SCImago Journal Rank (SJR) 0.106
h-index 5
Overall Rank 25753
Publisher Name Editorial office of Chinese Journal of Cancer Biotherapy
Publication Country China
International Standard Serial Number (ISSN) 1007385X
Coverage and History 2008-2011, 2013-2016, 2018-2022
Best Quartile Q4
Total Citations Received
(Last 3 Year)
30

About Chinese Journal of Cancer Biotherapy


Chinese Journal of Cancer Biotherapy is a journal published by Editorial office of Chinese Journal of Cancer Biotherapy. This journal covers the area[s] related to Cancer Research, Molecular Medicine, Pharmacology, etc. The coverage history of this journal is as follows: 2008-2011, 2013-2016, 2018-2022. The rank of this journal is 25753. This journal's impact score, h-index, and SJR are 0.06, 5, and 0.106, respectively. The ISSN of this journal is/are as follows: 1007385X.

The best quartile of Chinese Journal of Cancer Biotherapy is Q4. This journal has received a total of 30 citations during the last three years (Preceding 2022).


Chinese Journal of Cancer Biotherapy Impact Score 2022-2023


The latest impact score (IS) of the Chinese Journal of Cancer Biotherapy is 0.06. It is computed in the year 2023 as per its definition and based on Scopus data. 0.06

It is decreased by a factor of around 0.01, and the percentage change is -14.29% compared to the preceding year 2021, indicating a falling trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of Chinese Journal of Cancer Biotherapy Impact Score 2023


Impact Score 2022 of Chinese Journal of Cancer Biotherapy is 0.06. If a similar downward trend continues, IS may decrease in 2023 as well.


Impact Score Graph


Check below the Impact Score trends of Chinese Journal of Cancer Biotherapy. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 0.06
2021 0.07
2020 0.05
2019 0.05
2018 0.08
2017 0.03
2016 0.03
2015 0.04
2014 0.01

Chinese Journal of Cancer Biotherapy h-index


  Table Setting

The h-index of Chinese Journal of Cancer Biotherapy is 5. By definition of the h-index, this journal has at least 5 published articles with more than 5 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Chinese Journal of Cancer Biotherapy ISSN


The International Standard Serial Number (ISSN) of Chinese Journal of Cancer Biotherapy is/are as follows: 1007385X.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Chinese Journal of Cancer Biotherapy Ranking and SCImago Journal Rank (SJR)


The Chinese Journal of Cancer Biotherapy is ranked 25753 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 0.106.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Chinese Journal of Cancer Biotherapy Publisher


Table Setting

The publisher of Chinese Journal of Cancer Biotherapy is Editorial office of Chinese Journal of Cancer Biotherapy. The publishing house of this journal is located in the China. Its coverage history is as follows: 2008-2011, 2013-2016, 2018-2022.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


Abbreviation


The International Organization for Standardization 4 (ISO 4) abbreviation of Chinese Journal of Cancer Biotherapy is Chin. J. Cancer Biother.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('Chin. J. Cancer Biother.') can be used for citing, indexing, abstraction, and referencing purposes.


How to publish in Chinese Journal of Cancer Biotherapy


If your area of research or discipline is related to Cancer Research, Molecular Medicine, Pharmacology, etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Chinese Journal of Cancer Biotherapy?

The latest impact score of Chinese Journal of Cancer Biotherapy is 0.06. It is computed in the year 2023.


What is the h-index of Chinese Journal of Cancer Biotherapy?

The latest h-index of Chinese Journal of Cancer Biotherapy is 5. It is evaluated in the year 2023.


What is the SCImago Journal Rank (SJR) of Chinese Journal of Cancer Biotherapy?

The latest SCImago Journal Rank (SJR) of Chinese Journal of Cancer Biotherapy is 0.106. It is calculated in the year 2023.


What is the ranking of Chinese Journal of Cancer Biotherapy?

The latest ranking of Chinese Journal of Cancer Biotherapy is 25753. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.


Who is the publisher of Chinese Journal of Cancer Biotherapy?

Chinese Journal of Cancer Biotherapy is published by Editorial office of Chinese Journal of Cancer Biotherapy. The publication country of this journal is China.


What is the abbreviation of Chinese Journal of Cancer Biotherapy?

This standard abbreviation of Chinese Journal of Cancer Biotherapy is Chin. J. Cancer Biother..


Is "Chinese Journal of Cancer Biotherapy" a Journal, Conference or Book Series?

Chinese Journal of Cancer Biotherapy is a journal published by Editorial office of Chinese Journal of Cancer Biotherapy.


What is the scope of Chinese Journal of Cancer Biotherapy?

The scope of Chinese Journal of Cancer Biotherapy is as follows:

  • Cancer Research
  • Molecular Medicine
  • Pharmacology

For detailed scope of Chinese Journal of Cancer Biotherapy, check the official website of this journal.


What is the ISSN of Chinese Journal of Cancer Biotherapy?

The International Standard Serial Number (ISSN) of Chinese Journal of Cancer Biotherapy is/are as follows: 1007385X.


What is the best quartile for Chinese Journal of Cancer Biotherapy?

The best quartile for Chinese Journal of Cancer Biotherapy is Q4.


What is the coverage history of Chinese Journal of Cancer Biotherapy?

The coverage history of Chinese Journal of Cancer Biotherapy is as follows 2008-2011, 2013-2016, 2018-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Business: Theory and Practice Journal Vilnius Gediminas Technical University 13414 21 2.47
Journal of Business Finance and Accounting Journal Wiley-Blackwell Publishing Ltd 3221 84 3.68
Journal, Indian Academy of Clinical Medicine Journal Indian Academy of Clinical Medicine 24608 16 0.06
European Journal of Education Journal Wiley-Blackwell Publishing Ltd 6079 53 2.31
Sex Education Journal Routledge 5168 41 2.82
Syntax Journal Wiley-Blackwell Publishing Ltd 3422 29 0.93
Studies in Continuing Education Journal Routledge 6011 38 2.81
European Surgery - Acta Chirurgica Austriaca Journal Springer Medizin 16873 23 0.58
Exploration Geophysics Journal Taylor and Francis Ltd. 16383 48 1.17
Metascience Journal Springer Nature 13645 3 0.13

Check complete list




Chinese Journal of Cancer Biotherapy Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2023/2024 Updated Soon
2022 0.06
2021 0.07
2020 0.05
2019 0.05
2018 0.08
2017 0.03
2016 0.03
2015 0.04
2014 0.01



Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Cell Host and Microbe
Cell Press | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

Neuro-Oncology
Oxford University Press | United Kingdom

Clinical Cancer Research
American Association for Cancer Research Inc. | United States

Annual Review of Cancer Biology
Annual Reviews Inc. | United States

Drug Resistance Updates
Churchill Livingstone | United States

Trends in Cancer
Cell Press | United States

See All

Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Genome Medicine
BioMed Central Ltd. | United Kingdom

EMBO Molecular Medicine
Wiley-Blackwell | United Kingdom

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Experimental and Molecular Medicine
Korean Society of Med. Biochemistry and Mol. Biology | South Korea

Molecular Aspects of Medicine
Elsevier Ltd. | United Kingdom

Trends in Molecular Medicine
Elsevier Ltd. | United Kingdom

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Biomarker Research
BioMed Central Ltd. | United Kingdom

Cellular and Molecular Life Sciences
Birkhauser Verlag Basel | Switzerland

See All

Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Drug Resistance Updates
Churchill Livingstone | United States

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

npj Vaccines
Nature Publishing Group | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Trends in Pharmacological Sciences
Elsevier Ltd. | United Kingdom

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

American Journal of Transplantation
Wiley-Blackwell Publishing Ltd | United Kingdom

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Journal of Biomedical Science
BioMed Central Ltd. | United Kingdom

Acta Pharmaceutica Sinica B
Elsevier BV | Netherlands

See All